Literature DB >> 17371889

"I'm not ready for hospice": strategies for timely and effective hospice discussions.

David J Casarett1, Timothy E Quill.   

Abstract

Hospice programs offer unique benefits for patients who are near the end of life and their families, and growing evidence indicates that hospice can provide high-quality care. Despite these benefits, many patients do not enroll in hospice, and those who enroll generally do so very late in the course of their illness. Some barriers to hospice referral arise from the requirements of hospice eligibility, which will be difficult to eliminate without major changes to hospice organization and financing. However, the challenges of discussing hospice create other barriers that are more easily remedied. The biggest communication barrier is that physicians are often unsure of how to talk with patients clearly and directly about their poor prognosis and limited treatment options (both requirements of hospice referral) without depriving them of hope. This article describes a structured strategy for discussing hospice, based on techniques of effective communication that physicians use in other "bad news" situations. This strategy can make hospice discussions both more compassionate and more effective.

Entities:  

Mesh:

Year:  2007        PMID: 17371889     DOI: 10.7326/0003-4819-146-6-200703200-00011

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  19 in total

1.  Increasing hospice services for elderly patients maintained with hemodialysis.

Authors:  Lewis M Cohen; Robin Ruthazer; Michael J Germain
Journal:  J Palliat Med       Date:  2010-07       Impact factor: 2.947

Review 2.  Neurologists as primary palliative care providers: Communication and practice approaches.

Authors:  Claire J Creutzfeldt; Maisha T Robinson; Robert G Holloway
Journal:  Neurol Clin Pract       Date:  2016-02

3.  Should a reversible, but lethal, incident not be treated when a patient has a do-not-resuscitate order?

Authors:  Philip C Hébert; Debbie Selby
Journal:  CMAJ       Date:  2013-04-29       Impact factor: 8.262

4.  Treating chronically ill people with diabetes mellitus with limited life expectancy: implications for performance measurement.

Authors:  LeChauncy D Woodard; Cassie R Landrum; Tracy H Urech; Jochen Profit; Salim S Virani; Laura A Petersen
Journal:  J Am Geriatr Soc       Date:  2012-01-19       Impact factor: 5.562

5.  Preparing Older Patients With Serious Illness for Advance Care Planning Discussions in Primary Care.

Authors:  Nebras Abu Al Hamayel; Sarina R Isenberg; Joshua Sixon; Katherine Clegg Smith; Samantha I Pitts; Sydney M Dy; Susan M Hannum
Journal:  J Pain Symptom Manage       Date:  2019-05-07       Impact factor: 3.612

6.  Qualitative Study of Patients' and Caregivers' Perceptions and Information Preferences About Hospice.

Authors:  Areej El-Jawahri; Lara Traeger; Jennifer A Shin; Helen Knight; Kristina Mirabeau-Beale; Joel Fishbein; Harry H Vandusen; Vicki A Jackson; Angelo E Volandes; Jennifer S Temel
Journal:  J Palliat Med       Date:  2017-05-30       Impact factor: 2.947

7.  Preventive health care among older women: missed opportunities and poor targeting.

Authors:  Mara A Schonberg; Suzanne G Leveille; Edward R Marcantonio
Journal:  Am J Med       Date:  2008-11       Impact factor: 4.965

8.  The role of chemotherapy at the end of life: "when is enough, enough?".

Authors:  Sarah Elizabeth Harrington; Thomas J Smith
Journal:  JAMA       Date:  2008-06-11       Impact factor: 56.272

Review 9.  The Interventions to Reduce Acute Care Transfers (INTERACT) quality improvement program: an overview for medical directors and primary care clinicians in long term care.

Authors:  Joseph G Ouslander; Alice Bonner; Laurie Herndon; Jill Shutes
Journal:  J Am Med Dir Assoc       Date:  2014-03       Impact factor: 4.669

10.  Understanding their options: determinants of hospice discussion for older persons with advanced illness.

Authors:  John M Thomas; John R O'Leary; Terri R Fried
Journal:  J Gen Intern Med       Date:  2009-06-09       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.